CLINICAL ROLE OF INDIGENOUS DRUGS IN KULAJ PANDU (THALESSEMIA) - A SCIENTIFIC STUDY
*Dr. Nagesh Jaiswal and Prof. (Dr.) Swapnil Singhai
The thalessemia is a heterogeneous group of disorders with a genetically determined reduction in the rate of synthesis of one or more types of normal hemoglobin polypeptide chain. This results in a decrease in the amount of the hemoglobin involving the affected chain. In some forms of thalessemia, the genetic mutation results in the synthesis of structurally abnormal hemoglobin, which is produced at a reduced rate. Kulaj Pandu (Thalessemia) is quite fearful hereditary pediatric disease, which certainly ends the life of affected child. Pediatrics world is constantly following up of this notorious hereditary pediatric disease but still they are not in position to realize the mysterious factor of this disease because of this mysterious situation; scientists of pediatric world feel their inability to root out this fatal pediatric problem. The only remedy with them is to transfuse blood as a compensatory phenomenon. There is no specific drug and none of the pathies has conquered over this fatal pediatric disease up till now. The present study ‘role of some indigenous drugs in Kulaj Pandu (Thalessemia)’ is highlighted as - Patients of Group B treated with Amalki Rasayan and Gomed Bhasma were observed in better improving condition in comparison to patients of Group A, treated with only Amalki Rasayan. In both treated groups symptomatic improvement was observed but basic pathological structure remained unchanged. This reveals that significant symptomatic relief may be observed as a "Prabhavas" of virtuous properties of the drugs. Blood picture of the relevant study did not show any significant change; simultaneously duration of blood transfusion was also remained as such.
Keywords: Amalaki Rasayan, Gomed Bhasma, Kulaj Pandu, Thalessemia.
[Full Text Article]